Discovery of New Pentapeptide Inhibitors Against Amyloid-β Aggregation Using Word2Vec and Molecular Simulation
- 25 February 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (6) , 1055-1065
Abstract
Alzheimer's disease (AD) is characterized by the aggregation of amyloid-β (Aβ) peptides into toxic oligomers and fibrils. The efficacy of existing peptide inhibitors based on the central hydrophobic core (CHC) sequence of Aβ42 remains limited due to self-aggregation or poor inhibition. This study aimed to identify novel pentapeptide inhibitors with high similarity and low binding energy to the CHC region LVFFA using a new computational screening workflow based on Word2Vec and molecular simulation. The antimicrobial peptides and human brain protein sequences were used for training the Word2Vec model. After tuning the parameters of the Word2Vec model, 1017 pentapeptides with high similarity to LVFFA were identified. Molecular docking was employed to estimate the affinity of the pentapeptides for the target of Aβ14-42 pentamer, and 103 peptides with favorable docking scores were obtained. Finally, five pentapeptides with a low binding energy and high binding stability via molecular dynamics simulation were experimentally validated using thioflavin T assays. Surprisingly, one pentapeptide, i.e., PALIR, exhibited significant inhibition surpassing the positive control LPFFN. This study demonstrates an effective combinatorial strategy to discover new peptide inhibitors. With PALIR representing a promising lead candidate, further optimization of PALIR could aid in the development of improved therapies to prevent amyloid toxicity in AD.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFB3807301, 2022YFE0106100)
- National Natural Science Foundation of China (21878262, 22178299, 51933009)
This publication has 59 references indexed in Scilit:
- Hematoxylin modulates tau-RD protein fibrillization and ameliorates Alzheimer's disease-like symptoms in a yeast modelInternational Journal of Biological Macromolecules, 2023
- Alzheimer's disease drug development pipeline: 2023Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023
- QuoteTarget: A sequence‐based transformer protein language model to identify potentially druggable protein targetsProtein Science, 2023
- Proanthocyanidins prevent tau protein aggregation and disintegrate tau filamentsChinese Journal of Chemical Engineering, 2022
- Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluationBioorganic Chemistry, 2020
- Computation-aided engineering of starch-debranching pullulanase from Bacillus thermoleovorans for enhanced thermostabilityApplied Microbiology and Biotechnology, 2020
- Computational design and evaluation of β‐sheet breaker peptides for destabilizing Alzheimer's amyloid‐β 42 protofibrilsJournal of Cellular Biochemistry, 2019
- Definition and testing of the GROMOS force-field versions 54A7 and 54B7European Biophysics Journal, 2011
- Pentapeptide Amides Interfere with the Aggregation of β-Amyloid Peptide of Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 2002
- LINCS: A linear constraint solver for molecular simulationsJournal of Computational Chemistry, 1997